News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current NXS market cap is 28.88M. The company's latest EPS is USD -0.0363 and P/E is -2.75.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.8M | 9.09M | 11.75M | 22.28M | 22.92M |
| Operating Income | -12.19M | -9.47M | -12.7M | -15.95M | -10.3M |
| Net Income | -11.91M | -9.35M | -12.68M | -16.27M | -10.59M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 23.64M | 13.72M | 12.46M | 17.9M | 9.21M |
| Total Liabilities | 4.73M | 2.95M | 4.42M | 5.08M | 5.77M |
| Total Equity | 18.91M | 10.77M | 8.04M | 12.82M | 3.44M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.91M | -8.26M | -11.79M | -15.06M | -7.96M |
| Investing | -687k | -716k | -476k | -885k | -589k |
| Financing | 10.71M | 1.43M | 10.25M | 20.11M | 1.75M |
| Market Cap | 28.88M |
| Price to Earnings Ratio | -2.75 |
| Price to Sales Ratio | 1.27 |
| Price to Cash Ratio | 17.54 |
| Price to Book Ratio | 8.47 |
| Dividend Yield | - |
| Shares Outstanding | 291.7M |
| Average Volume (1 week) | 39.4k |
| Average Volume (1 Month) | 73.6k |
| 52 Week Change | -73.60% |
| 52 Week High | 0.50 |
| 52 Week Low | 0.081 |
| Spread (Intraday) | 0 (1%) |
| Company Name | Next Science Limited |
| Address |
level 14 sydney, new south wales 2000 |
| Website | https://www.nextscience.com/ |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
